WP1122

SKU: orb1472983

Description

WP-1122(WP 1122) is a candidate drug to treat SARS-COV-2(COVID-19) .2-DG completely prevented SARS-CoV–2 replication in Caco–2 cells. Glycolysis is a process by which cells convert glucose into energy and infected (host) cells are induced by viruses to dramatically increase their dependence on glycolysis. WP1122 is a prodrug of 2-DG whereby chemical elements are added to 2-DG to improve its delivery in vivo.

Key Properties

• CAS Number: 1204310-73-5
• MW: 248.229844093323
• Purity: >98%
• Formula: C₁₀H₁₆O₇
• SMILES: O1C(C[C@H]([C@@H]([C@H]1COC(C)=O)O)OC(C)=O)O

Storage & Handling

• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

44473138